Press Release – Hale Animal Health
Hale – Ginger cat with Best Life.
Leading the development of some of the world’s first clinically trialled and registered cannabis medicines for pets, Hale Animal Health is inviting the country’s vets to take a tour of New Zealand’s largest medicinal cannabis facility.
Part-owned by medicinal cannabis company, Helius Therapeutics, Hale Animal Health is set to host veterinarians at its joint headquarters. Those in attendance will hear more about the future of cannabidiol-based (CBD) products for New Zealand’s pets as well as first-hand international insights.
An update will be provided on the extensive R&D work now underway in the quest for Hale’s CBD veterinary-prescribed medicines to achieve approval by the country’s regulator, ACVM (Agricultural Compounds and Veterinary Medicines).